缂傚倸鍊搁崐鎼佸磹閹间礁纾归柟闂寸绾惧綊鏌熼梻瀵割槮缁炬儳婀遍埀顒傛嚀鐎氼參宕崇壕瀣ㄤ汗闁圭儤鍨归崐鐐差渻閵堝棗绗掓い锔垮嵆瀵煡鍩¢崒婊呯槇闂佹眹鍨藉ḿ褍鐡梻浣呵归鍛涘Δ鍛ラ柟鐑樻尵缁♀偓濠殿喗锕╅崢楣冨储閻㈠憡鈷戠紓浣姑悘锕傛嫅闁秵鐓冮梺鍨儏缁椦呯磼鏉堛劌娴柛鈹惧亾濡炪倖甯婇懗鍓佸姬閳ь剟姊洪幖鐐插姌闁告柨鐭傞崺鈧い鎺戝€归弳顒勬煛鐏炶濡奸柍瑙勫灴瀹曞崬鈽夐幍浣镐壕婵°倕鎳忛悡娑㈡倵閿濆骸澧柡瀣洴閺岋紕浠﹂崜褋鈧帡鏌嶈閸撱劎绱為崱妯碱洸闁割偅娲栫壕鍧楁煛閸愩劎澧涢柣鎾寸洴閹﹢鎮欐0婵嗘婵犳鍠栭崐鍧楀蓟閻旂⒈鏁婇柛婵嗗閸嬫挸鈹戦崱娆愭闂佸湱鍎ら崹鐔肺i崼鐔稿弿婵°倐鍋撴俊顐f⒒濡叉劙鏁撻敓锟� Simplified Chinese Email this article news.gov.hk
Case of NDM-1 Carbapenemase-producing Enterobacteriaceae under CHP investigation
*********************************************************

     The Public Health Laboratory Services Branch (PHLSB) of the Centre for Health Protection (CHP) of the Department of Health confirmed today (April 15) a case of New Delhi metallo-β-lactamase-1 (NDM-1) Carbapenemase-producing Enterobacteriaceae in a 5-year-old boy.

     The boy, with good past health, travelled to Pakistan from March 15 to April 5 and was admitted to a hospital there for fever and vomiting on March 28. He was diagnosed as acute renal failure and managed with haemodialysis and blood transfusion. He returned to Hong Kong and was admitted to Princess Margaret Hospital on April 5 for further management. His current condition is stable.

     The patient's blood grew NDM-1 Carbapenemase-producing Enterobacteriaceae as confirmed by the PHLSB.

     His family contacts are asymptomatic. Investigations by the CHP are underway.

     This is the 26th detected case of NDM Carbapenemase-producing Enterobacteriaceae in Hong Kong.

     NDM is an enzyme which can inactivate carbapenems and other beta-lactams such as penicillins. Bacteria harbouring this NDM gene are commonly resistant to multiple antimicrobials, limiting therapeutic options and rendering severe clinical infections difficult to treat. Most bacteria with the NDM enzyme remain susceptible to two types of antibiotics, colistin and tigecycline.

     Infections have varied from being asymptomatic to potentially life-threatening or fatal. The level of risk depends on which part of the body is affected by the infection, and the general health of the patient.

     NDM-producing Enterobacteriaceae was first reported in a Swedish patient of Indian origin who travelled to New Delhi, India, in 2008. The first fatal case was identified in 2010 in a patient who received medical treatment in Pakistan before being repatriated to Belgium.

     NDM-producing Enterobacteriaceae has now been reported in many countries and regions including Australia, Austria, Canada, Belgium, France, Germany, Japan, the Netherlands, Norway, Oman, Sweden, Singapore, Taiwan, the UK and the US. Most patients had prior hospital contact in the Indian subcontinent.

     A CHP spokesman said that proper use of antibiotics and personal hygiene, especially hand hygiene, are important for the prevention of emergence and cross-transmission of NDM strains.

Ends/Monday, April 15, 2013
Issued at HKT 19:53

NNNN

Print this page